Glow Blend

Glow Blend is a pre-mixed research combination vial containing three individually HPLC-verified peptides: BPC-157 (10mg, CAS 137525-51-0), GHK-Cu (50mg, CAS 49557-75-7), and TB-500 (10mg, CAS 77591-33-4) — 70mg total lyophilised content. Each component is independently verified at greater than or equal to 98% purity by HPLC before combination, providing researchers with a convenient single-reconstitution preparation covering three complementary signalling pathways.

Total mass: 70mg per vial | Composition: BPC-157 10mg + GHK-Cu 50mg + TB-500 10mg | Individual purity: greater than or equal to 98% each by HPLC | Form: Combined lyophilised powder | Appearance: Blue-green lyophilised powder (GHK-Cu copper complex imparts colour) | Storage: -20°C desiccated | Reconstitution: Bacteriostatic water recommended

The three components address distinct but complementary research pathways. BPC-157 has been studied in nitric oxide signalling (eNOS expression), VEGF and EGR-1 upregulation, FAK-paxillin pathway modulation, and actin cytoskeletal organisation — making it relevant to angiogenesis, vascular, and tissue biology research. GHK-Cu provides copper coordination chemistry research relevant to matrix metalloproteinase regulation, MMP/TIMP balance in ECM remodelling, SP1-mediated gene expression changes, and plasma copper transport biology. TB-500 contributes G-actin sequestration via its LKKTET actin-binding motif, directly modulating the G/F-actin ratio to influence cell migration, lamellipodia formation, and cytoskeletal dynamics.

The GHK-Cu copper(II) content should be considered when designing redox-sensitive assays or when quantifying ROS, as copper can participate in Fenton-type chemistry. For mechanistic studies requiring single-component attribution, BPC-157, GHK-Cu, and TB-500 are each available individually from Signal Labs.

For laboratory and analytical research purposes only. Not for human or veterinary use. No dosage or administration guidance is provided or implied.